Saturday, July 11, 2026

pharma · AML With Gene Mutations

Lomond Therapeutics Holdings

Lomond Therapeutics Holdings clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Lomond Therapeutics Holdings projects

1 ClinicalTrials.gov programs sponsored by Lomond Therapeutics Holdings.

Lomond Therapeutics Holdings has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ZE46-0134

    Lomond Therapeutics Holdings

    AML With Gene Mutations

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Lomond Therapeutics Holdings have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.